Carcinoma, Squamous Cell: all 1,779 studies
Page 10 of 18. Open to participants first (409), then studies with results posted, then the rest; newest registration first within each.
- Neoadjuvant Immunotherapy (PD-1 / PD-L1) Combined With Chemotherapy for Locally Advanced Thoracic Esophageal Squamous Cell Carcinoma: a Single Center, Prospective, Open, One Arm Exploratory Clinical StudyStatus unknownNCT05028231
- A Study of Docetaxel for Injection (Albumin-bound) in Combination With Nivolumab in Patients With Head and Neck (SCCHN)Status unknownNCT05027204Phase 1/2
- Tislelizumab Combined With Chemotherapy as Neoadjuvant Therapy for Stage IIIA-IIIB (N2) Lung Squamous Cell CarcinomaStatus unknownNCT05024266Phase 2
- Study of the Association Between Tumor Microenvironment Macrophages and Treatment Response in Squamous Cell Carcinoma of the Anal CanalStatus unknownNCT05019235
- Second-line Cabozantinib and Atezolizumab in Patients With Recurrent or Metastatic Esophageal Squamous Cell CarcinomaCompletedNCT05007613Phase 2
- PD-1 Inhibitor Combined With Neoadjuvant Chemotherapy in Subjects With Resectable Locally Advanced Thoracic Esophageal Squamous Cell CarcinomaStatus unknownNCT05007145Phase 2
- GR-MD-02 + Pembrolizumab Versus Pembrolizumab Monotherapy in Melanoma and Squamous Cell Head and Neck Cancer PatientsWithdrawnNCT04987996Phase 2
- Imgatuzumab in Patients With Advanced Cutaneous Squamous Cell CarcinomaWithdrawnNCT04985825Phase 2
- Chidamide Plus Camrelizumab as Second-line Therapy for Advanced ESCC Treated With PD-1 BlockadeStatus unknownNCT04984018Phase 2
- A Real-world Study of the Efficacy and Safety of Nimotuzumab in Combination With Chemoradiotherapy for LASCCHNCompletedNCT04949503
- Window of Opportunity Study of Preoperative Immunotherapy With Atezolizumab in Local SCCHNCompletedNCT04939480Phase 2
- The Neoadjuvant Treatment of Locally Advanced Thoracic Esophageal Squamous Cell CarcinomaStatus unknownNCT04937673Phase 2
- Efficacy and Safety of Immunotherapy Combined With Neoadjuvant Chemotherapy in Patients With Locally Advanced HPV (-) Head and Neck Squamous Cell Carcinoma: a Phase II Clinical TrialStatus unknownNCT04929067Phase 2
- Induction Chemotherapy Combined With Toripalimab in Locoregionally-Advanced Laryngo-Hypopharyngeal Squamous Cell CancerStatus unknownNCT04926753Phase 1
- Clinical Study of Camrelizumab in Combination With Neoadjuvant Chemotherapy for Operable Locally Advanced Head and Neck Squamous Cell CarcinomaStatus unknownNCT04922450Phase 2
- A Study of Concurrent Chemoradiation in Combination With or Without PD1 Inhibitor AB122 Adenosine 2a Receptor / Adenosine 2b Receptor Inhibitor AB928 Therapies in Locally Advanced Head and Neck CancersWithdrawnNCT04892875Phase 1
- Sintilimab and Nimotuzumab Combined With Chemotherapy for the Treatment of R/M HNSCC.Status unknownNCT04882462Phase 2
- Afatinib Plus Toripalimab in Previously Treated ESCC With EGFR Overexpression or EGFR AmplificationStatus unknownNCT04880811Phase 2
- Image-guided Proton Therapy for the Treatment of Locally Advanced Unresectable Head and Neck CancerCompletedNCT04870840Phase 1
- An Exploratory Clinical Study of SHR6390 and SHR1020 in the Treatment of Esophageal Squamous Cell Carcinoma After Progression on PD-1 AntibodyStatus unknownNCT04866381Phase 2
- First Line Weekly Chemo/Immunotherapy for Metastatic Head/Neck Squamous Cell Carcinoma PatientsActive, not recruitingNCT04858269Phase 2
- Radiotherapy Plus Durvalumab in Elderly Esophageal Squamous Cell CarcinomaStatus unknownNCT04851132Not applicable
- A Study to Evaluate Safety, Efficacy of Intralesional Injection of STP705 in Patients With isSCCCompletedNCT04844983Phase 2
- Toripalimab Plus Neoadjuvant Chemotherapy Combined With Chemoradiotherapy for Locally Advanced Unresectable Esophageal Squamous Cell CarcinomaActive, not recruitingNCT04844385Phase 2
- Combination 5-FU / Calcipotriene Cream for SCCIS/SCCStatus unknownNCT04839731Early Phase 1
- BI-754091 and Afatinib for Refractory Esophageal Squamous Cell Carcinoma (BEAR Study)CompletedNCT04839471Phase 2
- Re-irradiation With NBTXR3 in Combination With Pembrolizumab for the Treatment of Inoperable Locoregional Recurrent Head and Neck Squamous Cell CancerWithdrawnNCT04834349Phase 2
- Phase 2 Trial of Maintenance Cemiplimab for Head and Neck Squamous Cell Carcinoma (HNSCC)WithdrawnNCT04831450Phase 2
- A Study of NG-641 and Pembrolizumab in Squamous Cell Carcinoma of the Head and NeckCompletedNCT04830592Phase 1
- A Study to Assess Safety of Nivolumab in Routine Oncology Practice in ChinaCompletedNCT04825873
- Pepinemab in Combination With Pembrolizumab in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and NeckCompletedNCT04815720Phase 1/2
- HRQoL Keratinocyte CarcinomasStatus unknownNCT04814953
- A Multicenter Phase II Trial of Post-operative Concurrent Chemoradiotherapy Using Weekly Cisplatin With Tislelizumab for Patients With High-risk Head and Neck Squamous Cell Carcinoma：The POTENTIAL StudyStatus unknownNCT04814069Phase 2
- Study of Anlotinib Plus Sintilimab in the Treatment of Advanced Esophageal Squamous Cell CarcinomaStatus unknownNCT04813406Not applicable
- Toripalimab with Paclitaxel and Cisplatin As Neoadjuvant Treatment for Esophageal Squamous Cell CarcinomaTerminatedNCT04804696Phase 2
- Efficacy of Tislelizumab and Spartalizumab Across Multiple Cancer-types in Patients with PD1-high MRNA Expressing TumorsActive, not recruitingNCT04802876Phase 2
- SHR-1210 in Combination With Anlotinib in Patients With Advanced or Metastatic Esophageal Squamous Cell CancerStatus unknownNCT04797507Phase 2
- Concurent Chemoradiotherapy in Head and Neck CancersStatus unknownNCT04780750Phase 3
- Transoral Laser Surgery and Radiotheraphy for Early Stage Laryngeal Squamous Cell CancerCompletedNCT04778306Not applicable
- A Study of Camrelizumab Combined With Chemotherapy as Neoadjuvant Therapy in Adcanced Esophageal Squamous Cell Carcinoma (ESCC)Status unknownNCT04767295Phase 2
- Precisely Estimation of the Prognostic Value of Lymph Node in ESCCCompletedNCT04764240
- Phase II Study of Postoperative Concurrent Chemoradiotherapy for Esophageal Squamous Cell Carcinoma (ESO- Shanghai 17)Active, not recruitingNCT04764227Phase 2
- Multimodal Functional Imaging Combined With Metabolomics in Predicting the Efficacy of nCRT for Locally Advanced ESCCStatus unknownNCT04759235
- Camrelizumab Combined With Radiotherapy for Adjuvant Treatment of Esophageal Squamous Cell Carcinoma After SurgeryStatus unknownNCT04741490Not applicable
- Study of Pembrolizumab in the First Line Therapy for R/M HNSCC in ChinaStatus unknownNCT04740996
- JAB-3068 Activity in Adult Patients With Advanced Solid TumorsCompletedNCT04721223Phase 1/2
- Neoadjuvant Sintilimab in Combination With Carboplatin and Nab-paclitaxel in Resectable Oral Cavity or Oropharyngeal Squamous Cell CarcinomaActive, not recruitingNCT04718415Phase 2
- Prospective Trial to Evaluate the Safety and Efficacy to Treat Esophageal Cancer Using 5-FU, Oxaliplatin, and DocetaxelStatus unknownNCT04699994Phase 2
- Use of Electrical Impedance Spectroscopy (EIS) for Early Diagnosis of Skin DamageTerminatedNCT04688749
- Expanded Access Use of DKN-01 for the Treatment of Advanced Solid TumorsNo longer availableNCT04681248
- Cetuximab Plus Paclitaxel as First Line for Recurrent and/or Metastatic SCCHN: Real World Data.CompletedNCT04672772
- Sentinel Lymph Node Biopsy for Cutaneous Squamous Cell Carcinoma of the Head and NeckStatus unknownNCT04664582Not applicable
- Combination of Nimotuzumab and Radiotherapy for Recurrent Uterine Cervical Squamous CarcinomaStatus unknownNCT04664244Phase 2
- CAR-macrophages for the Treatment of HER2 Overexpressing Solid TumorsActive, not recruitingNCT04660929Phase 1
- Study of Pharmacokinetic, Safety, Immunogenicity and Efficacy of CMAB819 and Nivolumab in R/M HNSCCTerminatedNCT04659369Phase 1
- Study of First-line Camrelizumab With or Without Chemotherapy for Advanced Esophageal Squamous Cell CancerStatus unknownNCT04654403Not applicable
- SHR-1701 in Patients With Recurrent/Metastatic ScchnStatus unknownNCT04650633Phase 2
- Combination of Toripalimab and Neoadjuvant Chemoradiotherapy for Locally Advanced Esophageal Squamous Cell CarcinomaStatus unknownNCT04644250Phase 2
- Immunotherapy After Transplantation for Skin Cancer Prevention in Organ Transplant RecipientsWithdrawnNCT04642287Phase 2
- De-Escalation Protocol Of HPV Mediated Oropharyngeal Squamous Cell CarcinomaActive, not recruitingNCT04638465
- The Influence of Cancer Stem-cells on Risk of Relapse in Patients Harboring Adenocarcinoma and Squamous Cell Carcinoma of the LungCompletedNCT04634630
- Neoadjuvant Plus Adjuvant Treatment With Cemiplimab in Cutaneaous Squamous Cell CarcinomaActive, not recruitingNCT04632433Phase 2
- Tazemetostat and Pembrolizumab in Patients With Pembrolizumab- or Nivolumab-Resistant, Recurrent or Metastatic Head and Neck Squamous-Cell CarcinomaTerminatedNCT04624113Phase 1
- Study of IBI318 in Patients With Advanced Cutaneous Squamous Cell CarcinomaTerminatedNCT04611321Phase 1/2
- Study of Circulating Tumor DNA (ctDNA) Kinetics in Immuno-oncology (IO-KIN)CompletedNCT04606940
- Sintilimab Injection Combined With Concurrent CCRT in Locally Advanced Esophageal Squamous Cell CarcinomaStatus unknownNCT04602013Phase 2
- TiTAN-1: Safety, Proliferation and Persistence of GEN-011 Autologous Cell TherapyTerminatedNCT04596033Phase 1
- Chemo-embolization for Head and Neck CancerWithdrawnNCT04595981Phase 2
- A Prospective Randomized Controlled Study of Radiotherapy and the Concurrent Three-week and Single-week TP Chemotherapy for Advanced Cervical Squamous Cell Carcinoma and the Correlation Between HPV Classification and Sensitivity.Status unknownNCT04588090Not applicable
- NT-I7 for the Treatment of Recurrent Squamous Cell Carcinoma of Head and Neck Undergoing SurgeryTerminatedNCT04588038Phase 1
- The Aim of This Study is to Demonstrat That Vacuum-assisted Closure Versus Conventional Wound Closure Enables to Diminish Local Complications After Lymph Node Dissection in Patients With Metastatic Skin TumorsStatus unknownNCT04583605
- Pilot Study of Chemotherapy for HPV-Associated Oropharyngeal CancerCompletedNCT04572100Phase 1
- Study of Anti-PD-L1 in Combination With Chemo(Radio)Therapy for Resectable Esophageal Squamous Cell CarcinomaCompletedNCT04568200Phase 2
- Predicting Metastatic Oral Squamous Cell Carcinomas With Molecular Biomarkers Using Machine LearningStatus unknownNCT04543266
- Retreatment With Intratumoral Diffusing Alpha Radiation EmittersCompletedNCT04540588Not applicable
- A Phase Ⅱ Clinical Trial of Camrelizumab for Adjuvant Treatment of Resectable Esophageal Squamous Cell CarcinomaStatus unknownNCT04533490Phase 2
- A Biomarker-implemented Clinical Study Evaluating Mutations in MET and TP53 in a Population of Treatment-refractory Squamous Cell CarcinomaStatus unknownNCT04533321Phase 2
- Quantitative Evaluation of Metastatic Lymph Nodes With Dynamic 18F-FDG PET/CT in Patients With ESCCStatus unknownNCT04514822Not applicable
- Camrelizumab in Combination With Neoadjuvant Chemotherapy for Resectable Thoracic Esophageal Squamous Cell CarcinomaActive, not recruitingNCT04506138Phase 1/2
- First Time in Human Study of AZD8701 With or Without Durvalumab in Participants With Advanced Solid TumoursCompletedNCT04504669Phase 1
- Efficacy and Safety of Anlotinib Hydrochloride Combined With Nivolumab in the Treatment of Gastric and Esophageal CancerStatus unknownNCT04503967Phase 2
- A Study to Test BI 754091 Alone or in Combination With BI 836880 in People Who Have Advanced Anal CancerWithdrawnNCT04499352Phase 2
- Bispecific PSMAxCD3 Antibody CC-1 in Patients With Squamous Cell Carcinoma of the LungTerminatedNCT04496674Phase 1/2
- CCRT With Itraconazole in Locally Advanced Squamous Esophageal CancerStatus unknownNCT04481100Phase 2
- Neoadjuvant Toripalimab and Paclitaxel/Cisplatin on Pathological Response in Oral Squamous Cell Carcinoma PatientsCompletedNCT04473716Phase 1
- Safety and Preliminary Efficacy of SNK01 in Combination With Trastuzumab or Cetuximab in Subjects With Advanced HER2 or EGFR CancersWithdrawnNCT04464967Phase 1/2
- A Study of Anti-PD-L1 Antibody in Neoadjuvant Chemotherapy of Esophageal Squamous Cell Carcinoma.Status unknownNCT04460066Phase 1/2
- A Study of the Safety and Tolerance of CAN04 and Pembrolizumab in Combination With and Without Carboplatin and Pemetrexed in Subjects With Solid TumorsCompletedNCT04452214Phase 1
- Real-Time Monitoring of Chemotherapy Side-Effects in Patients With Gastrointestinal Cancers, RT-CAMSS StudyCompletedNCT04449679Not applicable
- Activity and Safety of Peptide-based Immunotherapy in Patients With Squamous Cell Carcinoma of the Head and Neck.TerminatedNCT04445064Phase 2
- Camrelizumab Combined With Apatinib Mesylate for Head and Neck Squamous Cell CarcinomaStatus unknownNCT04440917Phase 2
- Prevalence of Obstructive Sleep Apnea Hypopnea Syndrome (OSAHS) Following Squamous Cell Carcinomas of the Oropharynx Treatment by Combined ChemoradiotherapyStatus unknownNCT04440618
- Surveillance of Peripheral Blood of Lymphocyte and Immunocyte in Neoadjuvant Therapy Patients With Esophageal Squamous Cell Carcinoma (pLINE)Status unknownNCT04440332
- Neoadjuvant Chemoradiotherapy Combined With Perioperative Toripalimab in Locally Advanced Esophageal CancerStatus unknownNCT04437212Phase 2
- A Study of SBRT for Squamous Cell Carcinoma of the Head and NeckStatus unknownNCT04435938Phase 2
- Pre-Operative Pembrolizumab + Chemoradiation in Patients With Locally Advanced Esophageal Squamous Cell CarcinomaCompletedNCT04435197Phase 2
- Evaluation of Bintrafusp Alfa in Operable and Untreated Head and Neck Squamous Cell CarcinomaTerminatedNCT04428047Phase 2
- The Microbiome of Oesophageal Squamous Cell CarcinomaStatus unknownNCT04425122
- Carrimycin in Patients With Locally Advanced, Recurrent, or Metastatic HNSCC (Non NPC): A Phase I TrialCompletedNCT04413214Phase 1
- Imvamune Vaccine for the Treatment of Non-melanoma Skin CancerTerminatedNCT04410874Phase 1/2